Sexual Function Screening in Childhood Cancer Survivors
Assessing Patient Preferences and a Clinical Tool for Evaluating for Sexual Function in Adolescent and Young Adult Survivors of Childhood Cancer
2 other identifiers
observational
24
1 country
2
Brief Summary
This is a qualitative research study involving semistructured interviews and Think-Aloud methodology during completion of a clinical screening tool. All participants will undergo the same semistructured interviews.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2019
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2019
CompletedFirst Posted
Study publicly available on registry
August 26, 2019
CompletedStudy Start
First participant enrolled
September 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedJune 30, 2022
June 1, 2022
7 months
August 21, 2019
June 29, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Describe AYA CCS perspectives on implementation of screening for sexual dysfunction, including preferred modality, setting and timing for evaluating sexual dysfunction.
Qualitative interviews will be conducted by phone by a trained qualitative research interviewer. Interviews will be in-depth and semistructured, utilizing a combination of broad, open-ended questions and more specific probes. The interview guide was developed with the help of Dr. Michael Fisher, PhD, who has expertise in qualitative research methodology. The interviewer will take detailed field notes. This portion of the interview will last approximately 25-35 minutes and will be digitally recorded and professionally transcribed. After each interview, the interviewer will complete an Interview Summary Form, which will serve as a memoing tool and summarize initial themes or impressions that may be relevant to the research question.
1 year
Secondary Outcomes (1)
Assess AYA CCS perceptions of the PROMIS SexFS Brief, an existing adult clinical screening tool for sexual dysfunction, in a qualitative pilot study.
1 year
Study Arms (2)
age 15-19
The investigators plan to complete 24 interviews with 12 in the age 15-19 cohort.The investigators will also ensure that at least 8 people from each sex are included in this study.
age 20-24
The investigators plan to complete 24 interviews with 12 in the age 20-24 cohort. The investigators will also ensure that at least 8 people from each sex are included in this study.
Interventions
* Participation will serve as verbal consent. * Qualitative PRA will call participant to schedule either phone or in person interview. If via phone, the study PRA performing the interview, will remind them to find a private space to speak. * REDCap link will be sent for PROMIS SexFS Brief. * PRA will perform semistructured interview and guide Think-Aloud to complete the PROMIS SexFS Brief. * Participants will not submit responses to PROMIS SexFS Brief responses after completing the tool.
Eligibility Criteria
* Sample size * Max number of participants that can be enrolled is 30 * Max number of participants that can be interviewed is 24 * Gender Male and Female * Age Range 15-24 * Demographic group English-speaking * General health status Pediatric cancer survivors (diagnosed at \<18 years of age and now at least 2 years off therapy) * Geographic location Children's Hospital Colorado and University of Colorado Hospital
You may qualify if:
- Ability to read and understand the postcard consent.
- Stated willingness to comply with all study procedures and be available for the duration of the study.
- Age 15-24 at time of enrollment
- History of cancer diagnosis, diagnosed at \<18 years old
- Off therapy (chemotherapy, surgery, radiation) for a minimum of 2 years
- Sufficient cognitive functioning such that participants are able to complete study measures, as determined by their physician and research personnel.
You may not qualify if:
- Developmental or intellectual disability, as determined by the patient's physician
- Received neither chemotherapy nor radiation therapy
- Non-English speaking
- Non-English reading
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Colorado, Denverlead
- National Cancer Institute (NCI)collaborator
Study Sites (2)
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
Colorado School of Public Health, University of Colorado Denver
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 21, 2019
First Posted
August 26, 2019
Study Start
September 16, 2019
Primary Completion
April 7, 2020
Study Completion
June 1, 2022
Last Updated
June 30, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share